Mirion Technologies MIR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Medical Segment | $72.1M-12.6% | $82.5M+5.1% | $78.5M-3.3% | $81.2M+18.4% | $68.6M-19.9% | |
| Nuclear & Safety | $185.5M-4.8% | $194.9M+34.8% | $144.6M+2.0% | $141.7M+6.2% | $133.4M-20.9% | |
| Total revenues by Product | ||||||
| Cancer care | $55.3M-13.5% | $63.9M+3.1% | $62M-0.3% | $62.2M+22.0% | $51M-22.7% | |
| Labs and research | $28.3M-16.8% | $34M0.0% | $34M+24.1% | $27.4M+2.2% | $26.8M-26.8% | |
| Nuclear power | $125.8M— | —— | —— | —— | $84.1M— | |
| Other | $16.8M-51.2% | $34.4M+19.4% | $28.8M-10.6% | $32.2M+83.0% | $17.6M-48.7% | |
| Total revenues by Geography | ||||||
| Asia Pacific | $4.7M+6.8% | $4.4M+37.5% | $3.2M+45.5% | $2.2M-62.1% | $5.8M+93.3% | |
| Europe | $77.9M-25.6% | $104.7M+38.3% | $75.7M-7.5% | $81.8M+24.9% | $65.5M-31.4% | |
| North America | $175M+4.0% | $168.3M+16.7% | $144.2M+3.8% | $138.9M+6.3% | $130.7M-16.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Mirion Technologies break its business down?
- Mirion Technologies (MIR) reports total revenues by business across 2 parts — Medical Segment and Nuclear & Safety. Each is extracted from the segment footnotes and tracked over time.
- Where does Mirion Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Mirion Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.